Cargando…
Severe COVID-19 patients exhibit an ILC2 NKG2D(+) population in their impaired ILC compartment
Autores principales: | Gomez-Cadena, Alejandra, Spehner, Laurie, Kroemer, Marie, Khelil, Myriam Ben, Bouiller, Kevin, Verdeil, Grégory, Trabanelli, Sara, Borg, Christophe, Loyon, Romain, Jandus, Camilla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734385/ https://www.ncbi.nlm.nih.gov/pubmed/33318627 http://dx.doi.org/10.1038/s41423-020-00596-2 |
Ejemplares similares
-
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions
por: Ercolano, Giuseppe, et al.
Publicado: (2021) -
ILC2s: New Actors in Tumor Immunity
por: Ercolano, Giuseppe, et al.
Publicado: (2019) -
Development of Human ILCs and Impact of Unconventional Cytotoxic Subsets in the Pathophysiology of Inflammatory Diseases and Cancer
por: Calvi, Michela, et al.
Publicado: (2022) -
Peripheral Innate Lymphoid Cells Are Increased in First Line Metastatic Colorectal Carcinoma Patients: A Negative Correlation With Th1 Immune Responses
por: Loyon, Romain, et al.
Publicado: (2019) -
ILC1s and ILC3s Exhibit Inflammatory Phenotype in Periodontal Ligament of Periodontitis Patients
por: Li, Changyi, et al.
Publicado: (2021)